What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cholesterol
- Diabetes mellitus
His main research concerns Internal medicine, Endocrinology, Cholesterol, Diabetes mellitus and Obesity.
His Internal medicine research is multidisciplinary, incorporating elements of Type 2 diabetes and Cardiology.
His study explores the link between Cholesterol and topics such as Myocardial infarction that cross with problems in Atorvastatin, Randomized controlled trial and Coronary heart disease.
His work in Metabolic syndrome addresses issues such as Disease, which are connected to fields such as Bioinformatics and Gerontology.
His Risk factor study incorporates themes from Epidemiology, Coronary artery disease, National Cholesterol Education Program, Intensive care medicine and Risk assessment.
His studies deal with areas such as Physical therapy, Blood cholesterol and Therapeutic Lifestyle Changes as well as National Cholesterol Education Program.
His most cited work include:
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) (27339 citations)
- Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) (11814 citations)
- Diagnosis and Management of the Metabolic Syndrome An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement (8742 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Endocrinology, Cholesterol, Lipoprotein and Diabetes mellitus.
His studies link Cardiology with Internal medicine.
He combines subjects such as Framingham Risk Score and Atorvastatin with his study of Cardiology.
His Cholesterol research is multidisciplinary, incorporating perspectives in Coronary heart disease, Excretion and Metabolism.
The study incorporates disciplines such as Disease and Risk factor in addition to Diabetes mellitus.
A large part of his Metabolic syndrome studies is devoted to National Cholesterol Education Program.
He most often published in these fields:
- Internal medicine (78.42%)
- Endocrinology (59.72%)
- Cholesterol (40.38%)
What were the highlights of his more recent work (between 2006-2021)?
- Internal medicine (78.42%)
- Endocrinology (59.72%)
- Metabolic syndrome (13.57%)
In recent papers he was focusing on the following fields of study:
Scott M. Grundy focuses on Internal medicine, Endocrinology, Metabolic syndrome, Cholesterol and Cardiology.
His Internal medicine study combines topics in areas such as Diabetes mellitus and Type 2 diabetes.
His study looks at the relationship between Endocrinology and topics such as Risk factor, which overlap with Vascular disease.
His Metabolic syndrome research incorporates elements of Dyslipidemia, Disease, Atorvastatin, Pharmacology and Incidence.
Within one scientific family, Scott M. Grundy focuses on topics pertaining to Atherosclerotic cardiovascular disease under Cholesterol, and may sometimes address concerns connected to Physical therapy.
As part of one scientific family, Scott M. Grundy deals mainly with the area of Cardiology, narrowing it down to issues related to the Guideline, and often Intensive care medicine.
Between 2006 and 2021, his most popular works were:
- Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity (8375 citations)
- Effects of Torcetrapib in Patients at High Risk for Coronary Events (2489 citations)
- A genome-wide association search for type 2 diabetes genes in African Americans. (1727 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Diabetes mellitus
Internal medicine, Endocrinology, Obesity, Diabetes mellitus and Metabolic syndrome are his primary areas of study.
His study on Internal medicine is mostly dedicated to connecting different topics, such as Cardiology.
As a part of the same scientific family, Scott M. Grundy mostly works in the field of Endocrinology, focusing on Risk factor and, on occasion, Vascular disease and Gerontology.
The various areas that Scott M. Grundy examines in his Obesity study include Body mass index, Genetics and C-reactive protein.
His Diabetes mellitus course of study focuses on Heart disease and Biomarker, Medical laboratory and Clinical biochemistry.
His Metabolic syndrome research is multidisciplinary, relying on both Dyslipidemia and Incidence.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
